Catalent Inc (CTLT)
59.66
+0.66
(+1.12%)
USD |
NYSE |
Nov 21, 16:00
59.66
0.00 (0.00%)
Pre-Market: 20:00
Catalent Debt to Equity Ratio: 1.393 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.393 |
| June 30, 2024 | 1.361 |
| March 31, 2024 | 1.379 |
| December 31, 2023 | 1.358 |
| September 30, 2023 | 1.288 |
| June 30, 2023 | 1.052 |
| March 31, 2023 | 1.031 |
| December 31, 2022 | 0.988 |
| September 30, 2022 | 0.8945 |
| June 30, 2022 | 0.88 |
| March 31, 2022 | 0.9037 |
| December 31, 2021 | 0.9418 |
| September 30, 2021 | 0.9826 |
| June 30, 2021 | 0.7583 |
| March 31, 2021 | 0.7915 |
| December 31, 2020 | 0.8011 |
| September 30, 2020 | 0.8315 |
| June 30, 2020 | 0.8608 |
| March 31, 2020 | 1.145 |
| December 31, 2019 | 1.247 |
| September 30, 2019 | 1.300 |
| June 30, 2019 | 1.293 |
| March 31, 2019 | 1.349 |
| Date | Value |
|---|---|
| December 31, 2018 | 1.408 |
| September 30, 2018 | 1.490 |
| June 30, 2018 | 2.504 |
| March 31, 2018 | 2.599 |
| December 31, 2017 | 2.727 |
| September 30, 2017 | 2.028 |
| June 30, 2017 | 2.874 |
| March 31, 2017 | 3.188 |
| December 31, 2016 | 3.443 |
| September 30, 2016 | 3.153 |
| June 30, 2016 | 2.926 |
| March 31, 2016 | 3.103 |
| December 31, 2015 | 3.083 |
| September 30, 2015 | 3.155 |
| June 30, 2015 | 2.967 |
| March 31, 2015 | 4.019 |
| December 31, 2014 | 3.921 |
| September 30, 2014 | 3.606 |
| June 30, 2014 | -7.302 |
| March 31, 2014 | -6.753 |
| December 31, 2013 | -6.594 |
| September 30, 2013 | -6.988 |
| June 30, 2013 | -6.554 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7583
Minimum
Jun 2021
1.393
Maximum
Sep 2024
1.044
Average
0.9853
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.185 |
| Boston Scientific Corp | 0.5254 |
| Pfizer Inc | 0.7219 |
| Merck & Co Inc | 0.8568 |
| BioCardia Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.708B |
| Total Liabilities (Quarterly) | 6.166B |
| Shareholders Equity (Quarterly) | 3.542B |
| Current Ratio | 2.512 |
| Net Debt Paydown Yield | -0.15% |